Dr Kevin Kalinsky
Breast medical oncologist and director of the breast cancer program at the Winship Cancer Institute of Emory University, invited to discuss advances in hormone receptor–positive breast cancer treatment.
Best podcasts with Dr Kevin Kalinsky
Ranked by the Snipd community
Feb 24, 2025 • 21min
How to Treat Hormone Receptor Positive Cancer - Latest Advancements and Current Standard of Care in 2025
In this enlightening discussion, Dr. Kevin Kalinsky, a leading breast medical oncologist and director of the breast cancer program at Emory University's Winship Cancer Institute, shares groundbreaking insights into the treatment of hormone receptor-positive breast cancer. He emphasizes the role of OncotypeDX in determining chemotherapy for different menopausal statuses and delves into the promising implications of new therapies like Inavolisib and CDK4-6 inhibitors. The conversation also explores genomic assays and ongoing trials that may reshape future treatment protocols.
Nov 1, 2024 • 59min
Improving Outcomes with First-Line Endocrine-Based Therapy for Patients with HR-Positive, HER2-Negative Metastatic Breast Cancer
Prof. Francois-Clement Bidard from Institut Curie in Paris and Dr. Kevin Kalinsky from Winship Cancer Institute dive into enhancing treatments for HR-positive, HER2-negative metastatic breast cancer. They explore the role of CDK inhibitors in older patients and the impact of ESR1 mutations on treatment resistance. The discussion highlights the evolution of clinical trials, personalized therapies, and innovative strategies aimed at improving long-term patient outcomes. Together, they emphasize the importance of patient involvement and genetic insights in shaping treatment decisions.
